Skip to main content

Luxturna becomes first gene therapy approved to treat an inherited disease

luxturna gene therapy b0011097 artificial microrna scaffold
Joao Conde / MIT / Wellcome Images
Biomedicine just took a giant step forward in the U.S. This week, the U.S. Food and Drug Administration approved Luxturna, a form of gene therapy that seeks to treat retinal dystrophy, a rare eye condition affecting cells in the retina. This marks the first time the FDA has approved gene therapy for an inherited disease.

Specifically, Luxturna is a genetically modified virus that carries a healthy gene into a patient’s eye. Tests have shown “dramatic results,” per an NPR report, with treated patients able to see far more effectively than before. Consequently, many of those who received Luxturna treatment were able to perform certain tasks for the first time — patients could read, play sports, ride bikes, and go outside on their own thanks to their significantly improved vision.

“Today’s approval marks another first in the field of gene therapy — both in how the therapy works and in expanding the use of gene therapy beyond the treatment of cancer to the treatment of vision loss — and this milestone reinforces the potential of this breakthrough approach in treating a wide range of challenging diseases,” said FDA Commissioner Scott Gottlieb in a statement.

This has been a good year as a whole for gene therapy — in August, Kymriah became the first gene-therapy drug approved to treat leukemia, while Yescarta received FDA approval to treat lymphoma in October.

“The culmination of decades of research has resulted in three gene therapy approvals this year for patients with serious and rare diseases,” Gottlieb added. “I believe gene therapy will become a mainstay in treating, and maybe curing, many of our most devastating and intractable illnesses.”

While gene therapy could indeed be a long-awaited cure to many of these diseases, these treatments might also come with some pretty serious price tags. As NPR noted, the first gene therapy product costs a whopping $475,000, and Luxturna maker Spark Therapeutics has yet to reveal how much it will charge. But speculation suggests it could cost $1 million per patient.

“I think the price tag will be enormous — 20 or 30 times the annual wages of the typical American,” Dr. Peter Bach, director of the Center for Health Policy and Outcomes at the Memorial Sloan Kettering Cancer Center, told NPR. “For rare conditions like this, the question we need to ask ourselves is exactly how much wealth should be transferred from society to the investors in these companies. Without addressing that we are just letting the investors decide how much they can take.”

Editors' Recommendations

Lulu Chang
Former Digital Trends Contributor
Fascinated by the effects of technology on human interaction, Lulu believes that if her parents can use your new app…
Don’t buy the Meta Quest Pro for gaming. It’s a metaverse headset first
Meta Quest Pro enables 3D modeling in mixed reality.

Last week’s Meta Connect started off promising on the gaming front. Viewers got release dates for Iron Man VR, an upcoming Quest game that was previously a PS VR exclusive, as well as Among Us VR. Meta, which owns Facebook, also announced that it was acquiring three major VR game studios -- Armature Studio, Camouflaj Team, and Twisted Pixel -- although we don’t know what they’re working on just yet.

Unfortunately, that’s where the Meta Connect's gaming section mostly ended. Besides tiny glimpses and a look into fitness, video games were not the show's focus. Instead, CEO Mark Zuckerberg wanted to focus on what seemed to be his company’s real vision of VR's future, which involves a lot of legs and a lot of work with the Quest Pro, a mixed reality headset that'll cost a whopping $1,500.

Read more
Meet the game-changing pitching robot that can perfectly mimic any human throw
baseball hitter swings and misses

Who’s your favorite baseball pitcher? Shane McClanahan? Sandy Alcantara? Justin Verlander? Whoever you said, two of the top sports-tech companies in the U.S. -- Rapsodo and Trajekt Sports -- have teamed up to build a robot version of them, and the results are reportedly uncannily accurate.

Okay, so we’re not talking about walking-talking-pitching standalone robots, as great a sci-fi-tinged MLB ad as that would be. However, Rapsodo and Trajekt have combined their considerable powers to throw a slew of different technologies at the problem of building a machine that's able to accurately simulate the pitching style of whichever player you want to practice batting against -- and they may just have pulled it off, too.

Read more
The best portable power stations
EcoFlow DELTA 2 on table at campsite for quick charging.

Affordable and efficient portable power is a necessity these days, keeping our electronic devices operational while on the go. But there are literally dozens of options to choose from, making it abundantly difficult to decide which mobile charging solution is best for you. We've sorted through countless portable power options and came up with six of the best portable power stations to keep your smartphones, tablets, laptops, and other gadgets functioning while living off the grid.
The best overall: Jackery Explorer 1000

Jackery has been a mainstay in the portable power market for several years, and today, the company continues to set the standard. With three AC outlets, two USB-A, and two USB-C plugs, you'll have plenty of options for keeping your gadgets charged.

Read more